Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2020
A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient-Education Network in Dermatology (OPENED) task forceL Misery, A Belloni Fortina, M El Hachem, et al.The British Journal of Dermatology|March 17, 2020
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr studyS Philipp, A Menter, A F Nikkels, et al.Journal of the American Academy of Dermatology|February 1, 1993
Variability in the Michelin tire syndrome. A child with multiple anomalies, smooth muscle hamartoma, and familial paracentric inversion of chromosome 7qR E Schnur, A J Herzberg, N Spinner, et al.The British Journal of Dermatology|December 1, 2018
Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV studyL F Eichenfield, J Q Del Rosso, J K L Tan, et al.The Journal of Dermatological Treatment|November 23, 2020
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trialsK Reich, A M DeLozier, F P Nunes, et al.The British Journal of Dermatology|January 17, 2007
A systematic review of the safety of topical therapies for atopic dermatitisJ Callen, S Chamlin, L F Eichenfield, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 8, 2016
Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatmentD Ovejero, Y H Lim, A M Boyce, et al.The British Journal of Dermatology|September 24, 2020
Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension studyM J Cork, D Thaçi, L F Eichenfield, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 18, 2023
Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent eventsR Bissonnette, L F Eichenfield, E Simpson, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|May 7, 2019
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinionJ P Thyssen, M S de Bruin-Weller, A S Paller, et al.Pageof 9